Clinical Trial Update: Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

An update indicates that a Phase 1 study of TVB-2640 in men with metastatic castration-resistant prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• TVB-2640

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prostatic Neoplasms, Castration-Resistant | Phase 1 | Status: RECRUITING